Artgen Biotech PJSC (MIC:ABIO) Institutional Ownership: 0.11% (As of Sep. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIC:ABIO Artgen Biotech PJSC MIC:ABIO
17 GF Score
Price ₽45.06
View Full Analysis

What is Artgen Biotech PJSC Institutional Ownership?

Artgen Biotech PJSC MIC:ABIO -0.18% 17 Institutional Ownership is 0.11% as of Sep. 14, 2026. GuruFocus rates MIC:ABIO with a GF Score™ of 17/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Artgen Biotech PJSC's institutional ownership is 0.11%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Artgen Biotech PJSC's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Artgen Biotech PJSC's Float Percentage Of Total Shares Outstanding is 0.00%.


Artgen Biotech PJSC Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Artgen Biotech PJSC's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artgen Biotech PJSC Institutional Ownership Chart

Artgen Biotech PJSC Historical Data

The historical data trend for Artgen Biotech PJSC can be seen below:

2022-01-31 2022-02-28
Institutional Ownership 0.10 0.11
MIC:ABIO
17GF Score
Artgen Biotech PJSC MIC:ABIO
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artgen Biotech PJSC Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.11% mean?
Artgen Biotech PJSC (MIC:ABIO) has a Institutional Ownership of 0.11% as of Sep. 14, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Artgen Biotech PJSC and its competitors.
Is Artgen Biotech PJSC's Institutional Ownership too high?
Artgen Biotech PJSC's current Institutional Ownership is 0.11%. Overall, Artgen Biotech PJSC has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Artgen Biotech PJSC's Institutional Ownership compare to VRTX and REGN?
Artgen Biotech PJSC's Institutional Ownership of 0.11% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Artgen Biotech PJSC and its competitors. Artgen Biotech PJSC's current Institutional Ownership is 0.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artgen Biotech PJSC stock overvalued right now?
Artgen Biotech PJSC (MIC:ABIO) has a current Institutional Ownership of 0.11%. The current Institutional Ownership is 0.11%. Artgen Biotech PJSC's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Artgen Biotech PJSC (MIC:ABIO), the current Institutional Ownership is 0.11% as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Artgen Biotech PJSC Business Description

Address Prospect of the 60th Anniversary, Moscow, RUS, 117036
Artgen Biotech PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.
17GF Score

Get the complete analysis for MIC:ABIO

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₽45.06
Price